Report Detail
Global Transdermal Drug Delivery Systems Market Professional Survey Report 2019
- RnM3741522 |
- 12 September, 2019 |
- Global |
- 115 Pages |
- QYResearch |
- Pharma & Healthcare
Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.
The global Transdermal Drug Delivery Systems market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Transdermal Drug Delivery Systems volume and value at global level, regional level and company level. From a global perspective, this report represents overall Transdermal Drug Delivery Systems market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Transdermal Drug Delivery Systems in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Transdermal Drug Delivery Systems manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Hisamitsu
Mylan
GSK
Novartis
Teve(Actavis)
Johnson & Johnson
UCB
Teikoku Seiyaku
Bayer
Lingrui
Sanofi
Qizheng
Endo
Huarun 999
Haw Par
Nichiban
Mentholatum Company
Laboratoires Genevrier
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Fentanyl
Nitroglycerin
Estradiol
Nicotine
Other
Segment by Application
OTC
Rx
Table of Contents
Executive Summary
1 Industry Overview of Transdermal Drug Delivery Systems
- 1.1 Definition of Transdermal Drug Delivery Systems
- 1.2 Transdermal Drug Delivery Systems Segment by Type
- 1.2.1 Global Transdermal Drug Delivery Systems Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Fentanyl
- 1.2.3 Nitroglycerin
- 1.2.4 Estradiol
- 1.2.5 Nicotine
- 1.2.6 Other
- 1.3 Transdermal Drug Delivery Systems Segment by Applications
- 1.3.1 Global Transdermal Drug Delivery Systems Consumption Comparison by Applications (2014-2025)
- 1.3.2 OTC
- 1.3.3 Rx
- 1.4 Global Transdermal Drug Delivery Systems Overall Market
- 1.4.1 Global Transdermal Drug Delivery Systems Revenue (2014-2025)
- 1.4.2 Global Transdermal Drug Delivery Systems Production (2014-2025)
- 1.4.3 North America Transdermal Drug Delivery Systems Status and Prospect (2014-2025)
- 1.4.4 Europe Transdermal Drug Delivery Systems Status and Prospect (2014-2025)
- 1.4.5 China Transdermal Drug Delivery Systems Status and Prospect (2014-2025)
- 1.4.6 Japan Transdermal Drug Delivery Systems Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Transdermal Drug Delivery Systems Status and Prospect (2014-2025)
- 1.4.8 India Transdermal Drug Delivery Systems Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Transdermal Drug Delivery Systems
- 2.3 Manufacturing Process Analysis of Transdermal Drug Delivery Systems
- 2.4 Industry Chain Structure of Transdermal Drug Delivery Systems
3 Development and Manufacturing Plants Analysis of Transdermal Drug Delivery Systems
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Transdermal Drug Delivery Systems Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Transdermal Drug Delivery Systems
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Transdermal Drug Delivery Systems Production and Capacity Analysis
- 4.2 Transdermal Drug Delivery Systems Revenue Analysis
- 4.3 Transdermal Drug Delivery Systems Price Analysis
- 4.4 Market Concentration Degree
5 Transdermal Drug Delivery Systems Regional Market Analysis
- 5.1 Transdermal Drug Delivery Systems Production by Regions
- 5.1.1 Global Transdermal Drug Delivery Systems Production by Regions
- 5.1.2 Global Transdermal Drug Delivery Systems Revenue by Regions
- 5.2 Transdermal Drug Delivery Systems Consumption by Regions
- 5.3 North America Transdermal Drug Delivery Systems Market Analysis
- 5.3.1 North America Transdermal Drug Delivery Systems Production
- 5.3.2 North America Transdermal Drug Delivery Systems Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Transdermal Drug Delivery Systems Import and Export
- 5.4 Europe Transdermal Drug Delivery Systems Market Analysis
- 5.4.1 Europe Transdermal Drug Delivery Systems Production
- 5.4.2 Europe Transdermal Drug Delivery Systems Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Transdermal Drug Delivery Systems Import and Export
- 5.5 China Transdermal Drug Delivery Systems Market Analysis
- 5.5.1 China Transdermal Drug Delivery Systems Production
- 5.5.2 China Transdermal Drug Delivery Systems Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Transdermal Drug Delivery Systems Import and Export
- 5.6 Japan Transdermal Drug Delivery Systems Market Analysis
- 5.6.1 Japan Transdermal Drug Delivery Systems Production
- 5.6.2 Japan Transdermal Drug Delivery Systems Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Transdermal Drug Delivery Systems Import and Export
- 5.7 Southeast Asia Transdermal Drug Delivery Systems Market Analysis
- 5.7.1 Southeast Asia Transdermal Drug Delivery Systems Production
- 5.7.2 Southeast Asia Transdermal Drug Delivery Systems Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Transdermal Drug Delivery Systems Import and Export
- 5.8 India Transdermal Drug Delivery Systems Market Analysis
- 5.8.1 India Transdermal Drug Delivery Systems Production
- 5.8.2 India Transdermal Drug Delivery Systems Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Transdermal Drug Delivery Systems Import and Export
6 Transdermal Drug Delivery Systems Segment Market Analysis (by Type)
- 6.1 Global Transdermal Drug Delivery Systems Production by Type
- 6.2 Global Transdermal Drug Delivery Systems Revenue by Type
- 6.3 Transdermal Drug Delivery Systems Price by Type
7 Transdermal Drug Delivery Systems Segment Market Analysis (by Application)
- 7.1 Global Transdermal Drug Delivery Systems Consumption by Application
- 7.2 Global Transdermal Drug Delivery Systems Consumption Market Share by Application (2014-2019)
8 Transdermal Drug Delivery Systems Major Manufacturers Analysis
- 8.1 Hisamitsu
- 8.1.1 Hisamitsu Transdermal Drug Delivery Systems Production Sites and Area Served
- 8.1.2 Hisamitsu Product Introduction, Application and Specification
- 8.1.3 Hisamitsu Transdermal Drug Delivery Systems Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Mylan
- 8.2.1 Mylan Transdermal Drug Delivery Systems Production Sites and Area Served
- 8.2.2 Mylan Product Introduction, Application and Specification
- 8.2.3 Mylan Transdermal Drug Delivery Systems Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 GSK
- 8.3.1 GSK Transdermal Drug Delivery Systems Production Sites and Area Served
- 8.3.2 GSK Product Introduction, Application and Specification
- 8.3.3 GSK Transdermal Drug Delivery Systems Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Novartis
- 8.4.1 Novartis Transdermal Drug Delivery Systems Production Sites and Area Served
- 8.4.2 Novartis Product Introduction, Application and Specification
- 8.4.3 Novartis Transdermal Drug Delivery Systems Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Teve(Actavis)
- 8.5.1 Teve(Actavis) Transdermal Drug Delivery Systems Production Sites and Area Served
- 8.5.2 Teve(Actavis) Product Introduction, Application and Specification
- 8.5.3 Teve(Actavis) Transdermal Drug Delivery Systems Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Johnson & Johnson
- 8.6.1 Johnson & Johnson Transdermal Drug Delivery Systems Production Sites and Area Served
- 8.6.2 Johnson & Johnson Product Introduction, Application and Specification
- 8.6.3 Johnson & Johnson Transdermal Drug Delivery Systems Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 UCB
- 8.7.1 UCB Transdermal Drug Delivery Systems Production Sites and Area Served
- 8.7.2 UCB Product Introduction, Application and Specification
- 8.7.3 UCB Transdermal Drug Delivery Systems Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Teikoku Seiyaku
- 8.8.1 Teikoku Seiyaku Transdermal Drug Delivery Systems Production Sites and Area Served
- 8.8.2 Teikoku Seiyaku Product Introduction, Application and Specification
- 8.8.3 Teikoku Seiyaku Transdermal Drug Delivery Systems Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 Bayer
- 8.9.1 Bayer Transdermal Drug Delivery Systems Production Sites and Area Served
- 8.9.2 Bayer Product Introduction, Application and Specification
- 8.9.3 Bayer Transdermal Drug Delivery Systems Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 Lingrui
- 8.10.1 Lingrui Transdermal Drug Delivery Systems Production Sites and Area Served
- 8.10.2 Lingrui Product Introduction, Application and Specification
- 8.10.3 Lingrui Transdermal Drug Delivery Systems Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
- 8.11 Sanofi
- 8.12 Qizheng
- 8.13 Endo
- 8.14 Huarun 999
- 8.15 Haw Par
- 8.16 Nichiban
- 8.17 Mentholatum Company
- 8.18 Laboratoires Genevrier
9 Development Trend of Analysis of Transdermal Drug Delivery Systems Market
- 9.1 Global Transdermal Drug Delivery Systems Market Trend Analysis
- 9.1.1 Global Transdermal Drug Delivery Systems Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Transdermal Drug Delivery Systems Regional Market Trend
- 9.2.1 North America Transdermal Drug Delivery Systems Forecast 2019-2025
- 9.2.2 Europe Transdermal Drug Delivery Systems Forecast 2019-2025
- 9.2.3 China Transdermal Drug Delivery Systems Forecast 2019-2025
- 9.2.4 Japan Transdermal Drug Delivery Systems Forecast 2019-2025
- 9.2.5 Southeast Asia Transdermal Drug Delivery Systems Forecast 2019-2025
- 9.2.6 India Transdermal Drug Delivery Systems Forecast 2019-2025
- 9.3 Transdermal Drug Delivery Systems Market Trend (Product Type)
- 9.4 Transdermal Drug Delivery Systems Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Transdermal Drug Delivery Systems Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Transdermal Drug Delivery Systems. Industry analysis & Market Report on Transdermal Drug Delivery Systems is a syndicated market report, published as Global Transdermal Drug Delivery Systems Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Transdermal Drug Delivery Systems market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
